Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design.
TERRA, VS; Mills, DC; Yates, LE; ABOUELHADID, S; CUCCUI, J; WREN, BW;
2012
Journal of medical microbiology, (2012).61 Pt 7 10.1099/jmm.0.039438-0.
New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
BURCHETT, HE D; MOUNIER-JACK, S; GRIFFITHS, UK; Biellik, R; Ongolo-Zogo, P; Chavez, E; Sarma, H; Uddin, J; Konate, M; Kitaw, Y; Molla, M; Wakasiaka, S; GILSON, L; MILLS, A;
2012
Health policy and planning, (2012).27 Sup suppl 10.1093/heapol/czs035.
The role of publics in the introduction of new vaccines.
PATERSON, P; LARSON, HJ;
2012
Health policy and planning, (2012).27 Sup Suppl 10.1093/heapol/czs038.
Serotype replacement after pneumococcal vaccination.
MULHOLLAND, K; Satzke, C;
2012
Lancet, (2012).379 9824 10.1016/S0140-6736(12)60588-1.
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
Horowitz, A; HAFALLA, JC R; KING, E; Lusingu, J; Dekker, D; Leach, A; Moris, P; Cohen, J; Vekemans, J; Villafana, T; CORRAN, PH; Bejon, P; DRAKELEY, CJ; Von Seidlein, L; RILEY, EM;
2012
Journal of immunology (Baltimore, Md, (2012).188 10 10.4049/jimmunol.1102710.
Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira, SM; Barreto, ML; PILGER, D; Cruz, AA; Sant'Anna, C; Hijjar, MA; Ichihara, MY; SANTOS, AC; Genser, B; RODRIGUES, LC;
2012
The Lancet infectious diseases, (2012).12 4 10.1016/S1473-3099(11)70285-7.
A new challenge for the tuberculosis vaccine community?.
DOCKRELL, HM;
2012
The Journal of infectious diseases, (2012).205 7 10.1093/infdis/jis016.
Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites.
Ghumra, A; Semblat, J-P; Ataide, R; Kifude, C; Adams, Y; Claessens, A; Anong, DN; Bull, PC; Fennell, C; Arman, M; AMAMBUA-NGWA, A; Walther, M; CONWAY, DJ; Kassambara, L; Doumbo, OK; Raza, A; Rowe, JA;
2012
PLoS pathogens, (2012).8 4 10.1371/journal.ppat.1002665.
Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
Desai, R; Parashar, UD; Lopman, B; De Oliveira, LH; CLARK, AD; SANDERSON, CF B; Tate, JE; Matus, CR; Andrus, JK; Patel, MM;
2012
Clinical infectious diseases, (2012).54 10 10.1093/cid/cis191.
The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda.
Anderson, EJ; WEBB, EL; MAWA, PA; Kizza, M; Lyadda, N; Nampijja, M; ELLIOTT, AM;
2012
Vaccine, (2012).30 12 10.1016/j.vaccine.2012.01.053.